Volume 22 Issue 11
Nov.  2024
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2024  >  22(11): 1887-1890
XIAO Yong, JIN Shaowei, DONG Zhen, WANG Tianshu. Observation on the effect of Shen Yuanliang's prescription in treating CAG patients[J]. Chinese Journal of General Practice, 2024, 22(11): 1887-1890. doi: 10.16766/j.cnki.issn.1674-4152.003757
Citation: XIAO Yong, JIN Shaowei, DONG Zhen, WANG Tianshu. Observation on the effect of Shen Yuanliang's prescription in treating CAG patients[J]. Chinese Journal of General Practice, 2024, 22(11): 1887-1890. doi: 10.16766/j.cnki.issn.1674-4152.003757
shu

Observation on the effect of Shen Yuanliang's prescription in treating CAG patients

doi: 10.16766/j.cnki.issn.1674-4152.003757
  • 1.

    General Practice Department, Shaoxing Hospital of Traditional Chinese Medicine, Shaoxing, Zhejiang 312000, China

Funds:

 2023ZR135

  • Received Date: 2024-05-22
    Available Online: 2024-12-31
    Abstract
  •   Objective  To explore the improvement effect and mechanism of Shen Yuanliang's prescription in treating chronic atrophic gastritis (CAG) on gastric mucosal lesions.  Methods  A total of 105 CAG patients admitted to Shaoxing Hospital of Traditional Chinese Medicine from September 2020 to September 2023 were selected and randomly divided into Group A (53 cases) and Group B (52 cases) using a random number table method. Patients in Group B were treated with Western medicine, while patients in Group A were administered Shen Yuanliang's traditional Chinese medicine prescription in addition to the Western medicine treatment received by Group B. Before and after treatment, the patients' gastric mucosal histopathology scores, serum fibroblast growth factor 23 (FGF-23), cholinesterase (S-ChE), pepsinogen Ⅰ (PG Ⅰ), pepsinogen Ⅱ (PG Ⅱ), changes in traditional Chinese medicine syndrome scores, and clinical effects were compared.  Results  After treatment, the serum FGF-23 level in Group A was lower than that in Group B, while the serum S-ChE and PG Ⅰ levels were higher than those in Group B, with statistically significant differences (P < 0.05). Group A had lower scores for epigastric distention and pain, nausea and vomiting, qi stagnation and indigestion, belching, and acid reflux than Group B (P < 0.05). After treatment, Group A had lower scores for gastric mucosal atrophy, chronic inflammation, intestinal metaplasia, and intestinal dysplasia than Group B (P < 0.05). There were 32 cases of marked effectiveness, 18 cases of effectiveness, and 3 cases of ineffectiveness in Group A, while Group B had 20 cases of marked effectiveness, 24 cases of effectiveness, and 8 cases of ineffectiveness. The overall therapeutic effect was better in Group A than in Group B (Z=-2.402, P < 0.05).  Conclusion  The treatment of CAG patients with Shen Yuanliang's prescription can improve the gastric mucosal histopathological features more effectively, improve the levels of S-ChE, FGF-23, PG Ⅰ, and PG Ⅱ in serum and clinical symptoms, and the overall clinical effect is better.

     

    • FullText(HTML)
  • loading
    • References(23)
  • [1]
    苏博超, 冯博俊豪, 李昀珊, 等. 慢性萎缩性胃炎患者健康素养状况及相关影响因素分析[J]. 中华全科医学, 2023, 21(11): 1963-1966, 1971. doi: 10.16766/j.cnki.issn.1674-4152.003268

    SU B C, FENG B J H, LI Y S, et al. Health literacy status and related influencing factors of patients with chronic atrophic gastritis[J]. Chinese Journal of General Practice, 2023, 21(11): 1963-1966, 1971. doi: 10.16766/j.cnki.issn.1674-4152.003268
    [2]
    LERCH J M, PAI R K, BROWN I, et al. Interobserver agreement of estimating the extent of intestinal metaplasia in patients with chronic atrophic gastritis[J]. Virchows Arch, 2022, 480(6): 1277-1281. doi: 10.1007/s00428-021-03245-9
    [3]
    李萌, 于靖文, 丁媛, 等. 慢性萎缩性胃炎患者舌象、脉象与胃镜象相关性分析[J]. 辽宁中医杂志, 2024, 51(5): 10-14.

    LI M, YU J W, DING Y, et al. Correlation analysis of tongue, pulse and gastroscopy images in patients with chronic atrophic gastritis[J]. Liaoning Journal of Traditional Chinese Medicine, 2024, 51(5): 10-14.
    [4]
    中华医学会消化病学分会. 中国慢性胃炎共识意见(上)(2006, 上海)[J]. 中华消化杂志, 2007, 27(1): 45-50.

    Gastroenterology Branch of Chinese Medical Association. Consensus Opinion on Chronic Gastritis in China (Part 1)(2006, Shanghai)[J]. Chinese Journal of Digestion, 2007, 27(1): 45-50.
    [5]
    中华医学会消化病学分会. 中国慢性胃炎共识意见(下)(2006, 上海)[J]. 中华消化杂志, 2007, 27(2): 118-120.

    Gastroenterology Branch of Chinese Medical Association. Consensus Opinion on Chronic Gastritis in China (Part 2)(2006, Shanghai)[J]. Chinese Journal of Digestion, 2007, 27(2): 118-120.
    [6]
    中华中医药学会脾胃病分会. 慢性萎缩性胃炎中医诊疗共识意见[J]. 中医杂志, 2010, 51(8): 749-753.

    Chinese Association of Traditional Chinese Medicine Spleen and Stomach Diseases Branch. Consensus on Traditional Chinese Medicine Diagnosis and Treatment of Chronic Atrophic Gastritis[J]. Journal of Traditional Chinese Medicine, 2010, 51(8): 749-753.
    [7]
    周晶, 沈志祥, 沈磊. 慢性萎缩性胃炎内镜诊断与病理结果对照分析[J]. 中华消化内镜杂志, 2004, 21(2): 86-88.

    ZHOU J, SHEN Z X, SHEN L. Comparative analysis of endoscopic diagnosis and pathological results of chronic atrophic gastritis[J]. Chinese Journal of Digestive Endoscopy, 2004, 21(2): 86-88.
    [8]
    CHEN X Q, SHEN K, DENG Y Y, et al. A Randomized double-blind clinical trial of weierkang pills for the treatment of chronic atrophic gastritis[J]. J Clin Gastroenterol, 2023, 57(2): 165-171.
    [9]
    吴秀贞, 刘宗超, 覃向向, 等. 基于胃癌高发区人群筛查队列的不同胃黏膜病变进展为胃癌风险的前瞻性研究[J]. 中华流行病学杂志, 2022, 43(12): 1972-1978.

    WU X Z, LIU Z C, QIN X X, et al. Prospective study on the risk of gastric cancer progression from different gastric mucosal lesions based on screening cohorts in high-risk areas for gastric cancer[J]. Chinese Journal of Epidemiology, 2022, 43(12): 1972-1978.
    [10]
    贾凤娟, 汤小伟, 张学飞, 等. 健康体检人群胃肠镜检查的常见疾病危险因素分析[J]. 现代消化及介入诊疗, 2023, 28(1): 41-46.

    JIA F J, TANG X W, ZHANG X F, et al. Analysis of common disease risk factors in gastrointestinal endoscopy examination of health examination population[J]. Modern Digestion & Intervention, 2023, 28(1): 41-46.
    [11]
    李飞飞, 杨金艳, 韩瑞瑞, 等. 萎缩性胃炎患者外周血TLR4 MyD88 NF-κB及PG水平变化与Hp感染病变进程及炎症反应的关系[J]. 河北医学, 2023, 29(10): 1629-1634.

    LI F F, YANG J Y, HAN R R, et al. The relationship between changes in peripheral blood TLR4 MyD88 NF-κ B and PG levels and the progression of Hp infection and inflammatory response in patients with atrophic gastritis[J]. Hebei Medicine, 2023, 29(10): 1629-1634.
    [12]
    杨雁慧, 许彤丽, 史淑利. 两种含铋四联方案治疗幽门螺杆菌感染根除后复发疗效及其影响因素[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(3): 178-184.

    YANG Y H, XU T L, SHI S L. Efficacy and influencing factors of two bismuth containing quadruple therapy regimens for the treatment of recurrent Helicobacter pylori infection after eradication[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2022, 16(3): 178-184.
    [13]
    郭晓雪, 王萍, 李敬华, 等. 基于数据挖掘的慢性萎缩性胃炎中医证治规律分析[J]. 中国中医药信息杂志, 2024, 31(4): 38-43.

    GUO X X, WANG P, LI J H, et al. Analysis of Traditional Chinese Medicine diagnosis and treatment patterns of chronic atrophic gastritis based on data mining[J]. Chinese Journal of Information on Traditional Chinese Medicine, 2024, 31(4): 38-43.
    [14]
    杨锐平, 林小靖, 陶春晖, 等. 基于文献的慢性萎缩性胃炎中医证候特征及用药规律研究[J]. 世界中医药, 2023, 18(6): 871-876.

    YANG R P, LIN X J, TAO C H, et al. Study on Traditional Chinese Medicine syndrome characteristics and medication rules of chronic atrophic gastritis based on literature[J]. World Chinese Medicine, 2023, 18(6): 871-876.
    [15]
    何飞龙, 何巧飞, 张永力, 等. 从和论治肝胃不和型慢性萎缩性胃炎癌前病变的疗效及对中医症状积分的影响[J]. 山西医药杂志, 2021, 50(6): 938-940.

    HE F L, HE Q F, ZHANG Y L, et al. The therapeutic effect of treating precancerous lesions of chronic atrophic gastritis with liver stomach disharmony and its impact on traditional Chinese medicine symptom scores from the perspective of harmony[J]. Shanxi Medical Journal, 2021, 50(6): 938-940.
    [16]
    李力恒, 陈丽萍, 胡晓阳, 等. 柴胡的化学成分及药理作用研究进展[J]. 中医药学报, 2023, 51(2): 109-112.

    LI L H, CHEN L P, HU X Y, et al. Research progress on chemical components and pharmacological effects of Chaihu[J]. Acta Chinese Medicine and Pharmacology, 2023, 51(2): 109-112.
    [17]
    李星辰, 尹丽燕, 蔡红, 等. 温郁金化学成分、药理作用、临床应用的研究进展及其质量标志物的预测分析[J]. 中国中药杂志, 2023, 48(20): 5419-5437.

    LI X C, YIN L Y, CAI H, et al. Research progress on the chemical composition, pharmacological effects, clinical applications, and predictive analysis of quality markers of Wen Yu Jin[J]. China Journal of Chinese Materia Medica, 2023, 48(20): 5419-5437.
    [18]
    刘晓龙, 李春燕, 肖先, 等. 黄连主要活性成分及药理作用研究进展[J]. 新乡医学院学报, 2023, 40(8): 784-790.

    LIU X L, LI C Y, XIAO X, et al. Research progress on the main active ingredients and pharmacological effects of Huanglian[J]. Journal of Xinxiang Medical University, 2023, 40(8): 784-790.
    [19]
    靳伟跃, 程杰, 马娟娟, 等. 基于中医传承辅助平台的治疗慢性萎缩性胃炎方剂组方规律分析[J]. 中南药学, 2021, 19(10): 2179-2184.

    JIN W Y, CHENG J, MA J J, et al. Analysis of formula composition rules for the treatment of chronic atrophic gastritis based on Traditional Chinese Medicine inheritance assistance platform[J]. Central South Pharmacy, 2021, 19(10): 2179-2184.
    [20]
    段园志, 王微, 王韶华, 等. 基于数据挖掘分析名中医治疗胃痛组方用药规律[J]. 中国中医基础医学杂志, 2024, 30(5): 847-852.

    DUAN Y Z, WANG W, WANG S H, et al. Analysis of the medication patterns of traditional Chinese medicine formulas for treating stomach pain based on data mining[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2024, 30(5): 847-852.
    [21]
    黎玉仙, 陈秀芳, 金明娣. 疏肝和胃加减汤治疗慢性萎缩性胃炎疗效及对病理组织及血清炎性因子指标改善的研究[J]. 中华中医药学刊, 2021, 39(9): 200-203.

    LI Y X, CHEN X F, JIN M D. Study on the therapeutic effect of Shugan Hewei modified decoction on chronic atrophic gastritis and its improvement on pathological tissue and serum inflammatory factor indicators[J]. Chinese Archives of Traditional Chinese Medicine, 2021, 39(9): 200-203.
    [22]
    王雪花, 吴吉峰. 柴芍六君子汤加减联合四联疗法对Hp感染相关性慢性胃炎患者炎症反应及胃黏膜功能的影响[J]. 反射疗法与康复医学, 2023, 4(2): 45-48.

    WANG X H, WU J F. Effects of modified Chaishao Liujunzi Tang combined with quadruple therapy on inflammatory response and gastric mucosal function in patients with Hp infection related chronic gastritis[J]. Reflexology and Rehabilitation Medicine, 2023, 4(2): 45-48.
    [23]
    章向文, 何鹏, 郭田发, 等. 血清PGⅠ、PGⅡ及CEA水平联合检测诊断胃癌的实验研究[J]. 分子诊断与治疗杂志, 2022, 14(4): 593-596.

    ZHANG X W, HE P, GUO T F, et al. Experimental study on the combined detection of serum PG Ⅰ, PG Ⅱ, and CEA levels for the diagnosis of gastric cancer[J]. Journal of Molecular Diagnosis and Therapy, 2022, 14(4): 593-596.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (53) PDF downloads(1) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return